Evidence map›Paper›PMID 41670933›Full record

ArticleFEBS open bio2026

Identification of functional murine mitochondrial formyl peptides and their effects on myeloid-derived suppressor cell generation.

Miyako Ozawa, Saori Kagoshima, Akira Yamada

Abstract read
In one paragraph

Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miyako OzawaTumor Immunology Division, Research Center for Innovative Cancer Therapy, Kurume University, Japan.
Saori KagoshimaTumor Immunology Division, Research Center for Innovative Cancer Therapy, Kurume University, Japan.
Akira YamadaTumor Immunology Division, Research Center for Innovative Cancer Therapy, Kurume University, Japan.ORCID https://orcid.org/0000-0003-3157-9070

Funding

Ministry of Education, Culture, Sports, Science and Technology > Japan Society for the Promotion of Science KAKENHI Grant Number JP23K06755
6 · The paper itself

Abstract

N-formyl peptides are cleavage products of bacterial and mitochondrial proteins, which effects on neutrophil activation have been extensively studied. Mitochondrial formyl peptides are also known to play a role in tumor immunity, but the molecular mechanism underlying this role remains largely unexplored. Our previous work suggested that tumor-derived mitochondrial formyl peptides promote tumor growth by enhancing myeloid-derived suppressor cell (MDSC)-mediated cytotoxic T-lymphocyte suppression. Therefore, we hypothesized that tumor-derived mitochondrial formyl peptides act directly on bone marrow cells to promote MDSC generation. In this study, we tested this hypothesis by first identifying five functional murine mitochondrial formyl peptides that induced intracellular Ca

Indexed as

MitochondriaMyeloid-Derived Suppressor CellsPeptidesAnimalsBone Marrow CellsCalciumCells, CulturedChemotaxisGranulocyte-Macrophage Colony-Stimulating FactorMiceMice, Inbred C57BLReceptors, Formyl PeptideCalciumGranulocyte-Macrophage Colony-Stimulating FactorPeptidesReceptors, Formyl PeptideformylMDSCsmitochondriamousepeptidereceptors

Identifiers

PMID41670933
PMCPMC13327073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.